戻る Agenda
Session 11: Grand Q&A Panel
Speaker(s)
Ramesh Raghavachari, PhD
Supervisor, Unit 3/DPQA IV/OPQA I/OPQ/CDER, FDA, United States
Session 11: Grand Q and A Panel
Barry Ticho, MD, PhD
Chief Medical Officer, Stoke Therapeutics, United States
Speaker
Hobart Rogers, PharmD, PhD
Pharmacologist, CDER, FDA, United States
Speakers
Firoz Antia, PhD
Vice President, Oligonucleotide and Small Molecule CMC, Denali Therapeutics, United States
Speaker
Andreas Kuhn, PhD
Senior Vice President RNA Biochemistry & CMC Development, Biontech SE, Germany
Speaker
Jeffrey Foy, PhD
Executive Director, Toxicology, Nimbus Therapeutics, United States
Speaker
Ronald Wange, PhD
Principal Consultant, Aclairo Pharmaceutical Development Group, Inc., United States
Speaker